Global research priorities for noncommunicable diseases prevention, management, and control

International Journal of Noncommunicable Diseases

Volumn 2, Issue 4, 2017, Pages 107-112

  Sharma, Atul ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Chronic diseases; noncommunicable diseases; research priorities

Indexed keywords

EID: 85077392058     PISSN: 24688827     EISSN: 24688835     Source Type: Journal    
DOI: 10.4103/jncd.jncd_57_17     Document Type: Review

References (33)

1. Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020. Geneva: World Health Organization; 2013.
2. Bloom DE, Cafiero ET, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima S, et al. The Global Economic Burden of Non-communicable Diseases. Geneva: World Economic Forum; 2011.
3. th World Health Assembly; 2013.
4. Siegel KR, Patel SA, Ali MK. Non-communicable diseases in South Asia: Contemporary perspectives. Br Med Bull 2014;111:31-44.
5. Global Status Report on Noncommunicable Diseases 2010. Geneva: World Health Organization; 2010.
6. The Growing Danger of Non-Communicable Diseases: Acting Now to Reverse Course. Washington DC: The World Bank; 2011.
7. GBD 2013 DALYs and HALE Collaborators, Murray CJ, Barber RM, Foreman KJ, Abbasoglu Ozgoren A, Abd-Allah F, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: Quantifying the epidemiological transition. Lancet 2015;386:2145-91.
8. Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;386:743-800.
9. Global Strategy for the Prevention and Control of NCDs A53/14. Geneva: World Health Organization; 2000.
10. Nikolic IA, Stanciole AE, Zaydman M. Chronic Emergency: Why NCDs Matter. Health, Nutrition and Population (HNP) Discussion Paper. Washington DC: The World Bank; 2011.
11. Mendis S, Alwan A, editors. Prioritized Research Agenda for Prevention and Control of Noncommunicable Diseases. Geneva: World Health Organization; 2011.
12. Boutayeb A, Boutayeb S. The burden of non communicable diseases in developing countries. Int J Equity Health 2005;4:2.
13. Bloom DE, Cafiero-Fonseca ET, Candeias V, Adashi E, Bloom L, Gurfein L, et al. Economics of Non-Communicable Diseases in India: The Costs and Returns on Investment of Interventions to Promote Healthy Living and Prevent, Treat and Manage NCDs. Geneva: World Economic Forum, Harvard School of Public Health; 2014.
14. Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases. A/RES/66/2 United Nations General Assembly; 2012.
15. Health in 2015: from MDGs, Millennium Development Goals to SDGs, Sustainable Development Goals. France: World Health Organization; 2015.
16. From Burden to “Best Buys”: Reducing the Economic Impact of Non-Communicable Diseases in Low- and Middle-Income Countries. Geneva: World Economic Forum; 2011.
17. World Health Organization. Scaling up Action Against Noncommunicable Diseases: How Much Will it Cost? France: World Health Organization; 2011.
18. Maher D, Ford N, Unwin N. Priorities for developing countries in the global response to non-communicable diseases. Global Health 2012;8:14.
19. Zachariah R, Ford N, Maher D, Bissell K, Van den Bergh R, van den Boogaard W, et al. Is operational research delivering the goods? The journey to success in low-income countries. Lancet Infect Dis 2012;12:415-21.
20. World Health Organization. Stop the Global Epidemic of Chronic Disease: A Practical Guide to Successful Advocacy. Geneva: World Health Organization; 2006.
21. Sturke R, Vorkoper S, Duncan K, Levintova M, Parascondola M. Addressing NCDs through research and capacity building in LMICs: Lessonslearnedfromtobaccocontrol.GlobHealthAction2016;9:32407.
22. Maher D, Sekajugo J. Research on health transition in Africa: Time for action. Health Res Policy Syst 2011;9:5.
23. Lavis JN. How can we support the use of systematic reviews in policymaking? PLoS Med 2009;6:e1000141.
24. Goyet S, Touch S, Ir P, SamAn S, Fassier T, Frutos R, et al. Gaps between research and public health priorities in low income countries: Evidence from a systematic literature review focused on cambodia. Implement Sci 2015;10:32.
25. World NCD Federation; 2017. Available from: http://www.worldncdfederation.org/about/. [Last accessed on 2017 Dec 18].
26. Global Alliance for Chronic Diseases; 2017. Available from: https://www.gacd.org/about. [Last accessed on 2017 Dec 18].
27. Howson CP, Reddy KS, Ryan TJ, Bale JR, editors. Control of Cardiovascular Diseases in Developing Countries: Research, Development, and Institutional Strengthening. Washington DC: Committee on Research, Development, and Institutional Strengthening for Control of Cardiovascular Diseases in Developing Countries, Institute of Medicine; 1998.
28. Mathur P, Shah B. Research priorities for prevention and control of noncommunicable diseases in India. Indian J Community Med 2011;36:S72-7.
29. st ed. New Delhi: Wolters Kluwer Publishers; 2016.
30. Ruby A, Knight A, Perel P, Blanchet K, Roberts B. The effectiveness of interventions for non-communicable diseases in humanitarian crises: A Systematic review. PLoS One 2015;10:e0138303.
31. Ortegón M, Lim S, Chisholm D, Mendis S. Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-saharan africa and south east asia: Mathematical modelling study. BMJ 2012;344:e607.
32. st ed. New Delhi: Wolters Kluwer Publishers; 2016.
33. Noncommunicable Diseases and Their Risk Factors: ECOSOC’s Latest Task Force Resolution Calls for More Investment in NCDs; 2017. Available from: http://www.who.int/ncds/un-task-force/events/ecosoc-report-2017/en/. [Last accessed on 2017 Dec 18].